Evaluation
*
HighAbove AverageAverageBelow AverageLow
Jennifer Ang Chan, MD, MPH
Robin Sommers, NP
*
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Discuss how medical therapies fit within the wider range of treatment options available to patients with gastrointestinal or pancreatic neuroendocrine tumors
Define the role of mTOR inhibitors and tyrosine kinase inhibitors in patients with recurrent disease
Review the role of somatostatin analogs in patients with both functional and nonfunctional tumors
Describe best practices for preventing choloecystitis and other adverse reactions associated with medical therapy for pNETs
Recall key laboratory and imaging studies recommended for patients being trated for pNETs
*
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
This activity met my educational needs, expectations, and objectives
This activity was relevant to my practice
I feel confident treating patients in my practice based on this activity
This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months
The presentation was scientifically sound and free of commercial bias or influence
*
*
*
*
*